ArticlePloS one2024

Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections.

Miguel Figallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.